In patients with non-ST-elevation myocardial infarction (NSTEMI) and frailty, an initial invasive strategy caused early harm followed by late benefit, resulting in a neutral effect on survival at 3 ...
Medical Management/Treatment Initial treatment for suspected STEMI and NSTEMI requires a loading dose of nonenteric coated ASA at 162 to 325 mg (unless contraindicated), nitroglycerin in response to ...
In-hospital mortality was significantly lower in patients aged 90 years or older treated with PCI compared with medical management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results